Excision BioTherapeutics
Gene editing company developing CRISPR-based therapies to cure chronic viral infectious diseases including HIV and hepatitis B by directly excising integrated viral DNA from infected cells.
Website
https://www.excision.bio/Location
San Francisco, California, USA
Founded
2015
Investors
1
Categories
gene-editing, crispr, infectious-disease, hiv, therapeutics, biotech
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |
